120 related articles for article (PubMed ID: 19187993)
1. Dose escalation model for limited-stage small-cell lung cancer.
Arvidson NB; Khuntia D; Tomé WA
Radiother Oncol; 2009 Jun; 91(3):379-85. PubMed ID: 19187993
[TBL] [Abstract][Full Text] [Related]
2. Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2019 Jan; 20(1):13-19. PubMed ID: 30219240
[TBL] [Abstract][Full Text] [Related]
3. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
4. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
5. Thoracic Radiation in Limited Stage Small Cell Lung Cancer: Trends in Radiation Fractionation.
Kazemi M; Ladbury C; Liu J; Glaser S; Williams T; Amini A
Clin Lung Cancer; 2023 Jun; 24(4):322-328. PubMed ID: 36828750
[TBL] [Abstract][Full Text] [Related]
6. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation
with Concurrent Twice-daily Radiotherapy for Patients
with Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer.
Xia B; Hong LZ; Cai XW; Zhu ZF; Liu Q; Zhao KL; Fan M; Mao JF; Yang HJ; Wu KL; Fu XL
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):517-23. PubMed ID: 25481679
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
9. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.
Gazula A; Baldini EH; Chen A; Kozono D
Lung; 2014 Feb; 192(1):151-8. PubMed ID: 24162870
[TBL] [Abstract][Full Text] [Related]
10. Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
Hasan S; White R; Renz P; Abel S; Otaibi Z; Monga D; Colonias A; Wegner RE
Radiother Oncol; 2019 Mar; 132():23-26. PubMed ID: 30825965
[TBL] [Abstract][Full Text] [Related]
11. Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.
Viani GA; Gouveia AG; Matsuura FK; Jacinto AA; Moraes FY
Radiother Oncol; 2022 Aug; 173():41-48. PubMed ID: 35101470
[TBL] [Abstract][Full Text] [Related]
12. The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer.
Tomita N; Kodaira T; Hida T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1121-6. PubMed ID: 19665321
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
14. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
15. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
[TBL] [Abstract][Full Text] [Related]
17. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer.
Yee D; Butts C; Reiman A; Joy A; Smylie M; Fenton D; Chu Q; Hanson J; Roa W
Radiother Oncol; 2012 Feb; 102(2):234-8. PubMed ID: 21930323
[TBL] [Abstract][Full Text] [Related]
20. Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
Fenwick JD; Nahum AE; Malik ZI; Eswar CV; Hatton MQ; Laurence VM; Lester JF; Landau DB
Clin Oncol (R Coll Radiol); 2009 May; 21(4):343-60. PubMed ID: 19231143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
